These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 986754)

  • 1. Alterations in brain endogenous histamine levels in rats after chronic morphine treatment and morphine withdrawal.
    Mazurkiewicz-Kwilecki I; Henwood RW
    Agents Actions; 1976 Jul; 6(4):402-8. PubMed ID: 986754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of brain histamine in morphine addiction.
    Henwood RW; Mazurikiewicz-Kwilecki IM
    Life Sci; 1975 Jul; 17(1):55-6. PubMed ID: 1170474
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts.
    Ozaita A; Escribá PV; Ventayol P; Murga C; Mayor F; García-Sevilla JA
    J Neurochem; 1998 Mar; 70(3):1249-57. PubMed ID: 9489748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood-Brain Barrier.
    Chaves C; Gómez-Zepeda D; Auvity S; Menet MC; Crété D; Labat L; Remião F; Cisternino S; Declèves X
    J Pharm Sci; 2016 Jan; 105(1):350-8. PubMed ID: 26554626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine and methadone dependence in the rat: withdrawal and brain met-enkephalin levels.
    Pierce TL; Tiong GK; Olley JE
    Pharmacol Biochem Behav; 1992 May; 42(1):91-6. PubMed ID: 1528952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration in the brain content of substance P (1-7) during withdrawal in morphine-dependent rats.
    Zhou Q; Liu Z; Ray A; Huang W; Karlsson K; Nyberg F
    Neuropharmacology; 1998 Dec; 37(12):1545-52. PubMed ID: 9886677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine turnover in the brain of morphine-dependent mice.
    Oishi R; Nishibori M; Itoh Y; Saeki K; Fukuda T; Araki Y
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):58-63. PubMed ID: 3368014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
    Iwamoto ET; Ho IK; Way EL
    J Pharmacol Exp Ther; 1973 Dec; 187(3):588-67. PubMed ID: 4797745
    [No Abstract]   [Full Text] [Related]  

  • 9. Reciprocal (push-pull) effects of morphine on single units in the ventromedian and lateral hypothalamus and influences on other nuclei: with a comment on methadone effects during withdrawal from morphine.
    Kerr FW; Triplett JN; Beeler GW
    Brain Res; 1974 Jul; 74(1):81-103. PubMed ID: 4858825
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal.
    Kimes AS; London ED
    J Pharmacol Exp Ther; 1989 Feb; 248(2):538-45. PubMed ID: 2918470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of cerebral noradrenaline turnover after morphine withdrawal and its retardation by acute morphine administration in rats.
    Attila LM; Ahtee L
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):193-200. PubMed ID: 6541758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No relation of plasma morphine level to the severity of naloxone-induced withdrawal in acute morphine-dependent rats.
    Kishioka S; Inoue N; Nishida S; Fukunaga Y; Yamamoto H
    Jpn J Pharmacol; 1995 Nov; 69(3):187-93. PubMed ID: 8699626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal.
    Ozawa T; Nakagawa T; Shige K; Minami M; Satoh M
    Brain Res; 2001 Jun; 905(1-2):254-8. PubMed ID: 11423104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal.
    Kimes AS; Bell JA; London ED
    Neuroscience; 1990; 34(3):633-44. PubMed ID: 2352645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurosteroids in nicotine and morphine dependence.
    Concas A; Sogliano C; Porcu P; Marra C; Brundu A; Biggio G
    Psychopharmacology (Berl); 2006 Jun; 186(3):281-92. PubMed ID: 16133140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of afferent inputs to supraoptic nucleus oxytocin neurons during naloxone-precipitated morphine withdrawal in the rat.
    Murphy NP; Onaka T; Brown CH; Leng G
    Neuroscience; 1997 Sep; 80(2):567-77. PubMed ID: 9284358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of morphine on the brain histamine levels in stress-exposed rats.
    Eroğlu L
    Psychopharmacology (Berl); 1979 May; 63(1):13-5. PubMed ID: 112615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S; Ho IK
    Psychopharmacology (Berl); 1996 May; 125(2):135-40. PubMed ID: 8783387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroanatomical and chemical correlates of naloxone-precipitated withdrawal.
    Way EL; Loh HH; Ho IK; Iwamoto ET; Wei E
    Adv Biochem Psychopharmacol; 1973; 8(0):455-69. PubMed ID: 4604812
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus.
    Holmes PV; de Bartolomeis A; Koprivica V; Crawley JN
    Synapse; 1995 Mar; 19(3):197-205. PubMed ID: 7540319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.